Auf dieser Seite
01PTGX Preis
02Momentaufnahme
03Chart
06Performance
07Bewertung & Kennzahlen
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
25Handelssignale
26Meine Kennzahlen
PTGX Protagonist Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 5, 2026 10-K/10-Q Aug 5, 2026
$140,63
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$62,2452-Wochen-Tief
$160,8152-Wochen-Hoch
Marktkapitalisierung (MRQ)
$9.09B
P/E (TTM)
136.5
EPS (TTM)
$1.03
Umsatz (TTM)
$282M
Ihre Abzeichen
52W-Spanne
$62–$161
Analystenbewertung
BUY
Kursziel
$175
P/E
136.5
ROE
11.0%
Nettogewinnmarge
29.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
PTGX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$140.63
Marktkapitalisierung (MRQ)
$9.09B
P/E (TTM)
136.5
EPS (TTM)
$1.03
Umsatz (TTM)
$282M
ROE (TTM)
11.0%
52W-Spanne
$62–$161
PTGX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$46M2017-12-31 → 2025-12-31
EPS$-2.052020-12-31 → 2025-12-31
Freier Cashflow$56M2016-12-31 → 2025-12-31
Nettogewinnmarge29.4%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | PTGX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 136.55-Jahres-Durchschnitt ≈-13.4 | ≈-13.4 | · | · | |
| P/S (TTM) | 32.35-Jahres-Durchschnitt ≈45.3 | ≈45.3 | 28.1 | Fairer Wert | |
| K/B (MRQ) | 10.85-Jahres-Durchschnitt ≈4.9 | ≈4.9 | 8.1 | Überbewertet | |
| Kurs / FCF (TTM) | 69.65-Jahres-Durchschnitt ≈14.3 | ≈14.3 | · | · | |
| Kurs / Cashflow (TTM) | 69.35-Jahres-Durchschnitt ≈13.7 | ≈13.7 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 14.75-Jahres-Durchschnitt ≈4.9 | ≈4.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | PTGX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 20.7%5-Jahres-Durchschnitt ≈-279.2% | ≈-279.2% | -116.3% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 21.2%5-Jahres-Durchschnitt ≈-276.9% | ≈-276.9% | -116.3% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 29.9%5-Jahres-Durchschnitt ≈-257.3% | ≈-257.3% | 4.3% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 29.4%5-Jahres-Durchschnitt ≈-257.9% | ≈-257.9% | -94.2% | Spitzenklasse | |
| ROA (TTM) | 10.3%5-Jahres-Durchschnitt ≈-14.9% | ≈-14.9% | -20.7% | Im Einklang | |
| ROE (TTM) | 11.0%5-Jahres-Durchschnitt ≈-19.0% | ≈-19.0% | -10.4% | Unterdurchschnittlich | |
| ROIC | -25.9%5-Jahres-Durchschnitt ≈-23.9% | ≈-23.9% | -4.9% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | PTGX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 21.75-Jahres-Durchschnitt ≈11.5 | ≈11.5 | 7.5 | Starke Liquidität | |
| Quick Ratio | 12.55-Jahres-Durchschnitt ≈10.5 | ≈10.5 | 4.0 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | PTGX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -89.4%5-Jahres-Durchschnitt ≈130.6% | ≈130.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 20.1%5-Jahres-Durchschnitt ≈66.5% | ≈66.5% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 10.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | PTGX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.2 | ≈0.2 | 0.1 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$326.4K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
18.3%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 4, 2026 | $2.29 | $2.12 | 7.8% |
| 31. März 2026 | $0.05 | $-0.54 | 109.2% | |
| 31. Dezember 2025 | $-0.69 | $-0.50 | -38.5% | |
| 30. September 2025 | $-0.62 | $-0.65 | 4.9% | |
| 30. Juni 2025 | $-0.55 | $-0.59 | 6.8% | |
| 31. März 2025 | $-0.19 | $-0.24 | 19.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $46M | $434M | $60M | $27M | $27M | $29M | $231.0K | $31M | $20M | |
| R&D Expense | $159M | $138M | $120M | $126M | $126M | $75M | $65M | $59M | $46M | |
| SG&A Expense | $45M | $43M | $33M | $32M | $27M | $19M | $16M | $14M | $12M | |
| Operating Expenses | $204M | $182M | $154M | $158M | $153M | $93M | $81M | $73M | $58M | |
| Operating Income | $-158M | $253M | $-94M | $-131M | $-126M | $-65M | $-81M | $-42M | $-38M | |
| Interest Expense | · | · | · | · | · | $598.0K | $169.0K | · | · | |
| Interest Income | $29M | $26M | $15M | $4M | $443.0K | $900.0K | $3M | $3M | $948.0K | |
| Other Non-op | $27.0K | $250.0K | $-201.0K | $-80.0K | $-149.0K | $-46.0K | $-1.0K | $-20.0K | $-8.0K | |
| Pretax Income | $-129M | $279M | $-79M | $-127M | $-126M | $-65M | $-78M | $-40M | $-37M | |
| Income Tax | $838.0K | $4M | $0 | $0 | $0 | $1M | $-691.0K | $-799.0K | $0 | |
| Net Income | $-130M | $275M | $-79M | $-127M | $-126M | $-66M | $-77M | $-39M | $-37M | |
| EPS (Basic) | $-2.05 | $4.47 | $-1.39 | $-2.60 | $-2.71 | $-1.92 | · | · | · | |
| EPS (Diluted) | $-2.05 | $4.23 | $-1.39 | $-2.60 | $-2.71 | $-1.92 | · | · | · | |
| Shares (Basic) | 63,573,048 | 61,566,989 | 56,763,559 | 49,042,232 | 46,322,910 | 34,396,446 | · | · | · | |
| Shares (Diluted) | 63,573,048 | 65,077,722 | 56,763,559 | 49,042,232 | 46,322,910 | 34,396,446 | · | · | · | |
| EBITDA | $-157M | $254M | $-93M | $-130M | $-125M | $-64M | $-80M | $-42M | $-37M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $128M | $97M | $187M | $126M | $124M | $117M | $33M | $82M | $106M | |
| Short-term Investments | $439M | $322M | $155M | $112M | $203M | $188M | $100M | $47M | $38M | |
| Prepaid Expense | $10M | $8M | $4M | $6M | $9M | $6M | $6M | $3M | $4M | |
| Other Current Assets | $10.0K | $248.0K | $76.0K | $42.0K | · | · | · | · | $1M | |
| Current Assets | $578M | $592M | $356M | $243M | $341M | $316M | $145M | $138M | $151M | |
| PP&E (Net) | $4M | $3M | $1M | $2M | $2M | $1M | $2M | $861.0K | $879.0K | |
| PP&E (Gross) | $12M | $10M | $7M | $7M | $6M | $5M | $4M | $3M | $2M | |
| Accum. Depreciation | $8M | $7M | $6M | $5M | $4M | $3M | $3M | $2M | $2M | |
| Total Assets | $668M | $745M | $358M | $248M | $348M | $324M | $155M | $139M | $164M | |
| Accounts Payable | $5M | $2M | $772.0K | $4M | $2M | $3M | $3M | $6M | $1M | |
| Accrued Liabilities | $28M | $24M | $19M | $25M | $38M | $18M | $12M | $11M | $10M | |
| Current Liabilities | $45M | $47M | $21M | $31M | $44M | $40M | $35M | $26M | $43M | |
| Capital Leases | $8M | $10M | · | $1M | $4M | $4M | $6M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $121.0K | · | · | · | |
| Total Liabilities | $53M | $69M | $21M | $32M | $48M | $45M | $75M | $27M | $43M | |
| Long-term Debt | · | · | · | · | · | · | $10M | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | · | · | · | · | · | $0 | |
| Retained Earnings | $-471M | $-341M | $-616M | $-537M | $-409M | $-284M | $-218M | $-140M | $-102M | |
| AOCI | $641.0K | $-82.0K | $-105.0K | $-359.0K | $-299.0K | $28.0K | $-221.0K | $-233.0K | $-6.0K | |
| Stockholders' Equity | $615M | $675M | $337M | $216M | $300M | $280M | $80M | $113M | $121M | |
| Liabilities + Equity | $668M | $745M | $358M | $248M | $348M | $324M | $155M | $139M | $164M | |
| Shares Outstanding | 62,577,897 | 61,035,139 | 57,708,613 | 49,339,252 | 47,838,330 | 43,745,465 | 27,217,649 | 23,187,219 | 21,088,306 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $826.0K | $977.0K | $1M | $813.0K | $948.0K | $732.0K | $527.0K | $406.0K | |
| Stock-based Comp | $46M | $38M | $29M | $24M | $16M | $8M | $8M | $7M | $4M | |
| Deferred Tax | · | · | · | · | · | $1M | $-775.0K | $-799.0K | · | |
| Other Non-cash | $141M | $-129M | $-22M | $-6M | $478.0K | $-16M | $27M | $-18M | $36M | |
| Operating Cash Flow | $58M | $184M | $-70M | $-108M | $-108M | $-72M | $-42M | $-50M | $4M | |
| CapEx | $2M | $1M | $609.0K | $795.0K | $1M | $471.0K | $967.0K | $486.0K | $666.0K | |
| Investing Cash Flow | $-49M | $-299M | $-39M | $91M | $-16M | $-91M | $-54M | $2M | $16M | |
| Debt Issued | · | · | · | · | · | · | $10M | · | · | |
| Net Debt Issued | · | · | · | · | · | $-11M | · | · | · | |
| Stock Issued | · | · | $108M | · | $124M | $213M | $34M | $2M | · | |
| Net Stock Activity | · | · | $108M | · | $124M | $213M | $34M | $2M | · | |
| Financing Cash Flow | $23M | $26M | $170M | $19M | $130M | $248M | $46M | $24M | $66M | |
| Net Change in Cash | $31M | $-89M | $61M | $2M | $6M | $84M | $-49M | $-24M | $85M | |
| Taxes Paid | $4M | $2M | · | · | · | · | · | · | · | |
| Free Cash Flow | $56M | $183M | $-71M | $-109M | $-109M | $-73M | $-42M | $-50M | $3M | |
| Levered FCF | · | · | · | · | · | $-74M | $-43M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -343.6% | 58.2% | -156.1% | -494.2% | -460.0% | · | · | -136.7% | · | |
| Net Margin | -282.8% | 63.3% | -131.6% | -479.3% | -458.9% | · | · | -125.9% | · | |
| Pretax Margin | -281.0% | 64.3% | -131.6% | -479.3% | -458.9% | · | · | -128.4% | · | |
| EBITDA Margin | -340.9% | 58.4% | -154.5% | -490.4% | -457.0% | · | · | -135.0% | · | |
| ROA | -18.4% | 49.9% | -26.1% | -42.8% | -37.4% | -27.6% | -52.4% | -25.7% | -28.7% | |
| ROE | -20.3% | 45.6% | -24.7% | -55.5% | -39.9% | -29.4% | -88.0% | -32.9% | -35.5% | |
| ROIC | -25.9% | 36.9% | -27.8% | -60.9% | -41.9% | -23.5% | -99.8% | -38.3% | -31.4% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.7 | 12.5 | 16.7 | 7.8 | 7.7 | 7.8 | 4.1 | 5.3 | 3.5 | |
| Quick Ratio | 12.5 | 8.8 | 16.1 | 7.6 | 7.4 | 7.6 | 3.8 | 4.9 | 3.4 | |
| Interest Coverage | · | · | · | · | · | -107.9 | -476.5 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.8 | 0.2 | 0.1 | 0.1 | · | · | 0.2 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $9.82 | $11.06 | $5.83 | $4.37 | $6.27 | $6.39 | $2.94 | $4.85 | $5.72 | |
| Revenue / Share | $0.72 | $6.68 | $1.06 | $0.54 | · | · | · | · | · | |
| Cash Flow / Share | $0.91 | $2.83 | $-1.24 | $-2.21 | · | · | · | · | · | |
| Cash / Share | $2.05 | $1.59 | $3.24 | $2.55 | $2.59 | $2.68 | $1.21 | $3.55 | $5.03 | |
| EPS (TTM) | $-2.05 | $4.23 | $-1.39 | $-2.60 | $-2.71 | $-1.92 | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -89.4% | 624.1% | 125.7% | -2.8% | -4.4% | · | · | · | · | |
| Revenue CAGR 3Y | 20.1% | 151.3% | 28.0% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.0% | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $46M | $434M | $60M | $27M | $27M | $29M | $231.0K | $31M | $20M | |
| Net Income TTM | $-130M | $275M | $-79M | $-127M | $-126M | $-66M | $-77M | $-39M | $-37M | |
| Market Cap | $5.47B | $2.36B | $1.32B | $538M | $1.64B | $882M | $192M | $156M | $439M | |
| P/E | -42.6 | 9.1 | -16.5 | -4.2 | -12.6 | -10.5 | · | · | · | |
| P/S | 118.8 | 5.4 | 22.1 | 20.3 | 59.8 | 30.8 | 830.7 | 5.0 | 21.9 | |
| P/B | 8.9 | 3.5 | 3.9 | 2.5 | 5.5 | 3.2 | 2.4 | 1.4 | 3.6 | |
| P / Tangible Book | 8.9 | 3.5 | 3.9 | 2.5 | 5.5 | 3.2 | · | · | · | |
| P / Cash Flow | 94.8 | 12.8 | -18.8 | -5.0 | -15.2 | -12.2 | -4.6 | -3.1 | 113.3 | |
| P / FCF | 97.5 | 12.9 | -18.7 | -4.9 | -15.0 | -12.1 | -4.5 | -3.1 | 136.8 | |
| Earnings Yield | -2.4% | 11.0% | -6.1% | -23.8% | -7.9% | -9.5% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $213M | $56M | $7M | $5M | $6M | $28M | $171M | $5M | $4M | $255M | $60M | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $42M | $47M | $46M | $40M | $37M | $36M | $35M | $36M | $34M | $34M | $29M | $31M | $33M | $27M | $30M | $25M | |
| SG&A Expense | $13M | $13M | $11M | $11M | $11M | $12M | $9M | $10M | $9M | $15M | $8M | $8M | $9M | $9M | $7M | $7M | |
| Operating Expenses | $55M | $60M | $58M | $51M | $48M | $48M | $44M | $46M | $43M | $49M | $37M | $38M | $42M | $36M | $37M | $32M | |
| Operating Income | $159M | $-4M | $-50M | $-46M | $-42M | $-19M | $127M | $-41M | $-39M | $206M | $23M | $-38M | $-42M | $-36M | $-37M | $-32M | |
| Interest Income | $6M | $6M | $7M | $7M | $7M | $8M | $7M | $8M | $7M | $4M | $4M | $4M | $4M | $2M | $2M | $1M | |
| Other Non-op | $-81.0K | $53.0K | $-124.0K | $33.0K | $36.0K | $82.0K | $31.0K | $141.0K | $97.0K | $-19.0K | $44.0K | $-31.0K | $-19.0K | $-195.0K | $71.0K | $-86.0K | |
| Pretax Income | $165M | $2M | $-44M | $-39M | $-35M | $-12M | $134M | $-34M | $-31M | $211M | $27M | $-34M | $-38M | $-34M | · | · | |
| Income Tax | $2M | $-2M | $666.0K | $0 | $172.0K | $0 | $2M | $-420.0K | $-676.0K | $3M | · | $0 | $0 | $0 | · | · | |
| Net Income | $163M | $4M | $-44M | $-39M | $-35M | $-12M | $132M | $-33M | $-31M | $207M | $27M | $-34M | $-38M | $-34M | $-34M | $-31M | |
| EPS (Basic) | $2.47 | $0.06 | $-0.69 | $-0.62 | $-0.55 | $-0.19 | $2.10 | $-0.54 | $-0.50 | $3.41 | $0.54 | $-0.58 | $-0.68 | $-0.67 | $-0.69 | $-0.64 | |
| EPS (Diluted) | $2.29 | $0.05 | $-0.69 | $-0.62 | $-0.55 | $-0.19 | $2.01 | $-0.54 | $-0.50 | $3.26 | $0.54 | $-0.58 | $-0.68 | $-0.67 | $-0.69 | $-0.64 | |
| Shares (Basic) | 65,935,769 | 65,087,847 | · | 63,772,332 | 63,510,537 | 62,963,806 | · | 61,767,934 | 61,305,289 | 60,855,689 | · | 59,182,899 | 56,775,742 | 50,573,650 | · | 49,107,639 | |
| Shares (Diluted) | 71,007,011 | 70,492,618 | · | 63,772,332 | 63,510,537 | 62,963,806 | · | 61,767,934 | 61,305,289 | 63,595,328 | · | 59,182,899 | 56,775,742 | 50,573,650 | · | 49,107,639 | |
| EBITDA | $159M | $-3M | · | $-46M | $-42M | $-19M | · | $-41M | $-39M | $207M | · | $-38M | $-42M | $-36M | · | $-32M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $420M | $194M | $128M | $114M | $169M | $140M | $97M | $131M | $356M | $173M | $187M | $231M | $235M | $128M | $126M | $153M | |
| Short-term Investments | $362M | $354M | $439M | $462M | $402M | $435M | $322M | $338M | $208M | $150M | · | $90M | $78M | $103M | · | $115M | |
| Prepaid Expense | $8M | $12M | $10M | $10M | $9M | $9M | $8M | $8M | $7M | $5M | · | $4M | $4M | $5M | · | $9M | |
| Other Current Assets | · | · | $10.0K | $191.0K | $92.0K | · | $248.0K | $3M | $1M | $360.0K | · | $65.0K | · | · | · | · | |
| Current Assets | $807M | $613M | $578M | $586M | $603M | $606M | $592M | $477M | $571M | $628M | · | $325M | $317M | $236M | · | $277M | |
| PP&E (Net) | $3M | $4M | $4M | $4M | $4M | $4M | $3M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $2M | |
| PP&E (Gross) | $13M | $12M | $12M | $12M | $12M | $11M | $10M | $9M | $8M | $8M | · | $7M | $7M | $7M | · | $7M | |
| Accum. Depreciation | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | · | $6M | $6M | $5M | · | $5M | |
| Other Non-current Assets | $832.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $886M | $697M | $668M | $702M | $718M | $742M | $745M | $604M | $615M | $629M | · | $330M | $320M | $240M | · | $282M | |
| Accounts Payable | $3M | $8M | $5M | $6M | $3M | $3M | $2M | $3M | $4M | $4M | · | $1M | $5M | $4M | · | $5M | |
| Accrued Liabilities | $22M | $17M | $28M | $23M | $15M | $12M | $24M | $21M | $15M | $16M | · | $25M | $19M | $17M | · | $30M | |
| Current Liabilities | $37M | $35M | $45M | $45M | $36M | $35M | $47M | $45M | $42M | $40M | · | $28M | $26M | $23M | · | $37M | |
| Capital Leases | $7M | $7M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | · | · | · | · | $462.0K | · | $2M | |
| Total Liabilities | $44M | $42M | $53M | $56M | $50M | $53M | $69M | $72M | $73M | $69M | · | $28M | $26M | $24M | · | $39M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | $1.0K | $1.0K | $1.0K | · | · | |
| Retained Earnings | $-304M | $-467M | $-471M | $-426M | $-387M | $-352M | $-341M | $-472M | $-439M | $-408M | · | $-643M | $-609M | $-570M | · | $-503M | |
| AOCI | $-828.0K | $-269.0K | $641.0K | $525.0K | $-15.0K | $85.0K | $-82.0K | $1M | $-249.0K | $-229.0K | · | $-170.0K | $-198.0K | $-122.0K | · | $-480.0K | |
| Stockholders' Equity | $842M | $655M | $615M | $645M | $668M | $689M | $675M | $532M | $541M | $560M | $337M | $302M | $294M | $216M | $216M | $244M | |
| Liabilities + Equity | $886M | $697M | $668M | $702M | $718M | $742M | $745M | $604M | $615M | $629M | · | $330M | $320M | $240M | · | $282M | |
| Shares Outstanding | 64,672,032 | 64,227,057 | 62,577,897 | 62,447,102 | 62,107,572 | 61,928,760 | 61,035,139 | 59,521,903 | 58,762,063 | 58,600,787 | 57,708,613 | 57,647,476 | 57,494,185 | 51,440,503 | 49,339,252 | 49,198,411 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $397.0K | $407.0K | $376.0K | $361.0K | $304.0K | $239.0K | $118.0K | $231.0K | $241.0K | $236.0K | $248.0K | $244.0K | $237.0K | $248.0K | $256.0K | $270.0K | |
| Stock-based Comp | $14M | $15M | $11M | $11M | $11M | $14M | $9M | $10M | $9M | $9M | $7M | $7M | $8M | $8M | $6M | $6M | |
| Other Non-cash | · | $-68M | · | · | · | $123M | · | · | · | $-244M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $219M | $-49M | $-37M | $-2M | $-29M | $125M | $-29M | $-28M | $269M | $-27M | $17M | $-27M | $-26M | $-34M | $-32M | $-25M | |
| CapEx | $168.0K | $215.0K | $144.0K | $88.0K | $813.0K | $545.0K | $310.0K | $775.0K | $28.0K | $242.0K | $19.0K | $404.0K | $176.0K | $10.0K | $70.0K | $162.0K | |
| Investing Cash Flow | $-2M | $91M | $49M | $-59M | $55M | $-94M | $-9M | $-209M | $-88M | $6M | $-61M | $-14M | $26M | $10M | $4M | $57M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $8.0K | $-78.0K | · | · | · | · | |
| Financing Cash Flow | $10M | $23M | $3M | $6M | $3M | $11M | $4M | $12M | $3M | $7M | $527.0K | $35M | $108M | $26M | $553.0K | $680.0K | |
| Net Change in Cash | $226M | $65M | $15M | $-55M | $29M | $42M | $-34M | $-225M | $183M | $-14M | $-44M | $-5M | $108M | $2M | $-27M | $33M | |
| Free Cash Flow | · | $-49M | · | · | · | $125M | · | · | · | $-28M | · | · | · | $-34M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 74.4% | -6.5% | · | -985.2% | -758.0% | -68.2% | · | -886.7% | -931.0% | 80.9% | · | · | · | · | · | · | |
| Net Margin | 76.3% | 6.7% | · | -834.9% | -627.0% | -41.1% | · | -710.4% | -734.7% | 81.3% | · | · | · | · | · | · | |
| Pretax Margin | 77.3% | 4.0% | · | -834.9% | -623.9% | -41.1% | · | -719.4% | -751.0% | 82.6% | · | · | · | · | · | · | |
| EBITDA Margin | 74.4% | -5.8% | · | -985.2% | -758.0% | -67.3% | · | -886.7% | -931.0% | 81.0% | · | · | · | · | · | · | |
| ROA | 20.3% | 0.53% | · | -6.0% | -5.2% | -1.7% | · | -7.1% | -6.6% | 47.7% | · | -11.1% | -12.2% | -11.5% | · | -9.5% | |
| ROE | 21.6% | 0.56% | · | -6.7% | -5.8% | -1.9% | · | -8.0% | -7.3% | 53.4% | · | -12.5% | -13.7% | -13.0% | · | -10.9% | |
| ROIC | 18.6% | -0.92% | · | -7.2% | -6.3% | -2.8% | · | -7.7% | -7.0% | 36.2% | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.7 | 17.8 | · | 13.0 | 17.0 | 17.3 | · | 10.7 | 13.7 | 15.7 | · | 11.7 | 12.0 | 10.1 | · | 7.5 | |
| Quick Ratio | 21.0 | 15.9 | · | 12.8 | 16.1 | 16.4 | · | 10.5 | 13.6 | 8.1 | · | 11.5 | 11.9 | 9.9 | · | 7.3 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.6 | · | 0.0 | 0.0 | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.01 | $10.21 | · | $10.34 | $10.76 | $11.13 | · | $8.94 | $9.21 | $9.56 | · | $5.24 | $5.11 | $4.20 | · | $4.95 | |
| Revenue / Share | $3.01 | $0.80 | · | $0.07 | $0.09 | $0.45 | · | $0.08 | $0.07 | $4.01 | · | $0.00 | $0.00 | · | · | · | |
| Cash Flow / Share | · | $-0.69 | · | · | · | $1.99 | · | · | · | $-0.43 | · | · | · | $-0.68 | · | · | |
| Cash / Share | $6.50 | $3.02 | · | $1.82 | $2.71 | $2.26 | · | $2.20 | $6.05 | $2.94 | · | $4.00 | $4.09 | $2.48 | · | $3.11 | |
| EPS (TTM) | $1.03 | $-1.81 | · | $0.65 | $0.73 | $0.78 | · | $2.76 | $2.72 | $2.54 | · | $-2.62 | $-2.68 | $-2.84 | · | $-2.69 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $282M | $74M | · | $209M | $209M | $208M | · | $324M | $319M | $315M | · | $0 | $0 | $859.0K | · | $35M | |
| Net Income TTM | $83M | $-115M | · | $46M | $52M | $56M | · | $171M | $170M | $162M | · | $-140M | $-138M | $-140M | · | $-130M | |
| Market Cap | $7.93B | $6.77B | · | $4.15B | $3.43B | $2.99B | · | $2.68B | $2.04B | $1.70B | · | $962M | $1.59B | $1.18B | · | $415M | |
| P/E | 119.0 | -58.2 | · | 102.2 | 75.7 | 62.0 | · | 16.3 | 12.7 | 11.4 | · | -6.4 | -10.3 | -8.1 | · | -3.1 | |
| P/S | 28.1 | 91.4 | · | 19.8 | 16.4 | 14.4 | · | 8.3 | 6.4 | 5.4 | · | · | · | 1377.3 | · | 11.8 | |
| P/B | 9.4 | 10.3 | · | 6.4 | 5.1 | 4.3 | · | 5.0 | 3.8 | 3.0 | · | 3.2 | 5.4 | 5.5 | · | 1.7 | |
| P / Tangible Book | 9.4 | 10.3 | · | 6.4 | 5.1 | 4.3 | · | 5.0 | 3.8 | 3.0 | · | 3.2 | 5.4 | 5.5 | · | 1.7 | |
| P / Cash Flow | · | -138.3 | · | · | · | 23.9 | · | · | · | -61.8 | · | · | · | -34.4 | · | · | |
| Earnings Yield | 0.84% | -1.7% | · | 0.98% | 1.3% | 1.6% | · | 6.1% | 7.8% | 8.8% | · | -15.7% | -9.7% | -12.3% | · | -31.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $46M | $434M | $60M | $27M | $27M |
| Betriebsgewinnmarge % | -343.6% | 58.2% | -156.1% | -494.2% | -460.0% |
| Nettoergebnis | $-130M | $275M | $-79M | $-127M | $-126M |
| Verwässerte EPS | $-2.05 | $4.23 | $-1.39 | $-2.60 | $-2.71 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 12.7 | 12.5 | 16.7 | 7.8 | 7.7 |
| Quick Ratio | 12.5 | 8.8 | 16.1 | 7.6 | 7.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $56M | $183M | $-71M | $-109M | $-109M |
Institutionelle Eigentümer (13F) 367 Einreicher · $9.5B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
367
Gehaltener Wert
$9.5B
Neue Positionen
64
Geschlossene Positionen
34
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 64 (+2 vs. Vorquartal) | 34 (-14 vs. Vorquartal) | 143 (+30 vs. Vorquartal) | 90 (-17 vs. Vorquartal) | +3.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $1.263.534.678 | 10.307.837 | 13,28% | Aktien |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $778.248.897 | 6.348.906 | 8,18% | Aktien |
| RTW INVESTMENTS, LP | $620.398.832 | 5.061.175 | 6,52% | Aktien |
| VANGUARD GROUP INC | $472.831.684 | 5.413.690 | 4,97% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $444.879.349 | 3.629.298 | 4,68% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $418.829.015 | 3.416.781 | 4,40% | Aktien |
| UBS Group AG | $416.676.511 | 3.399.221 | 4,38% | Aktien |
| STATE STREET CORP | $407.156.089 | 3.321.554 | 4,28% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $349.769.037 | 2.853.394 | 3,68% | Aktien |
| JANUS HENDERSON GROUP PLC | $304.866.424 | 2.891.527 | 3,20% | Aktien |
| JOHNSON & JOHNSON | $300.220.852 | 2.449.183 | 3,16% | Aktien |
| Invesco Ltd. | $286.918.961 | 2.340.667 | 3,02% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $213.475.772 | 1.741.209 | 2,24% | Aktien |
| Woodline Partners LP | $173.349.326 | 1.414.173 | 1,82% | Aktien |
| BANK OF AMERICA CORP /DE/ | $162.356.964 | 1.324.498 | 1,71% | Aktien |
| JENNISON ASSOCIATES LLC | $141.173.058 | 1.151.681 | 1,48% | Aktien |
| PERCEPTIVE ADVISORS LLC | $120.358.728 | 981.879 | 1,27% | Aktien |
| ADAR1 Capital Management, LLC | $117.782.587 | 960.863 | 1,24% | Aktien |
| MORGAN STANLEY | $111.056.578 | 905.992 | 1,17% | Aktien |
| Alyeska Investment Group, L.P. | $109.010.149 | 889.298 | 1,15% | Aktien |
| Hood River Capital Management LLC | $108.206.024 | 882.738 | 1,14% | Aktien |
| GOLDMAN SACHS GROUP INC | $99.639.398 | 812.852 | 1,05% | Aktien |
| Driehaus Capital Management LLC | $89.612.477 | 731.053 | 0,94% | Aktien |
| Clearbridge Investments, LLC | $88.911.554 | 725.335 | 0,93% | Aktien |
| FMR LLC | $82.396.533 | 672.186 | 0,87% | Aktien |
| NORTHERN TRUST CORP | $81.651.153 | 666.105 | 0,86% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $73.376.587 | 598.600 | 0,77% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $71.559.017 | 583.774 | 0,75% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $70.068.935 | 571.618 | 0,74% | Aktien |
| Pictet Asset Management Holding SA | $69.624.214 | 567.990 | 0,73% | Aktien |
| FRANKLIN RESOURCES INC | $63.745.523 | 520.032 | 0,67% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $53.659.027 | 437.747 | 0,56% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $47.225.415 | 385.262 | 0,50% | Aktien |
| Bank of New York Mellon Corp | $43.920.414 | 358.300 | 0,46% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $37.071.502 | 302.427 | 0,39% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $36.954.438 | 301.472 | 0,39% | Aktien |
| 683 Capital Management, LLC | $35.548.200 | 290.000 | 0,37% | Aktien |
| Nuveen, LLC | $34.823.140 | 284.085 | 0,37% | Aktien |
| Stephens Investment Management Group LLC | $34.546.967 | 281.832 | 0,36% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $31.867.368 | 259.972 | 0,34% | Aktien |
| Eagle Health Investments LP | $30.439.311 | 248.322 | 0,32% | Aktien |
| NEXTBio Capital Management LP | $26.885.839 | 219.333 | 0,28% | Aktien |
| SEGALL BRYANT & HAMILL, LLC | $26.320.868 | 214.724 | 0,28% | Aktien |
| SEB Asset Management AB | $25.737.215 | 209.963 | 0,27% | Aktien |
| Public Sector Pension Investment Board | $25.458.395 | 207.688 | 0,27% | Aktien |
| CITIGROUP INC | $24.352.723 | 198.668 | 0,26% | Aktien |
| JPMORGAN CHASE & CO | $22.569.540 | 183.098 | 0,24% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $21.836.172 | 178.152 | 0,23% | Aktien |
| Affinity Asset Advisors, LLC | $21.099.083 | 172.125 | 0,22% | Aktien |
| Fisher Asset Management, LLC | $20.902.831 | 170.524 | 0,22% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Lilly Ventures Fund I, LLC, LV Management Group, LLC, S. Edward Torres, Steven E. Hall, Ph.D., Armen B. Shanafelt, Ph.D. ×2 Einreichungen | 8. Juni 2020 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 20 Insider · 10 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| PATEL DINESH V PH D | President and CEO | 10. September 2026 M | 522.968 | 0 | 14 | $-60.578.256 |
| Asif Ali | Chief Financial Officer | 30. September 2026 M | 59.003 | 0 | 7 | $-15.627.745 |
| Donald A. Kalkofen | Chief Financial Officer | 15. Februar 2022 A | 18.521 | 0 | 0 | $0 |
| Thomas P. O'Neil | Chief Financial Officer | 15. August 2018 A | 30.560 | 0 | 0 | $0 |
| Arturo Molina MD | Chief Medical Officer | 26. März 2026 M | 84.115 | 0 | 6 | $-4.491.766 |
| Suneel Gupta | Chief Development Officer | 26. November 2024 M | 267.433 | 0 | 0 | $0 |
| David Y Liu | Chief R&D Strategy Officer | 16. November 2022 M | 167.590 | 0 | 0 | $0 |
| Samuel R Saks | Chief Medical Officer | 26. Februar 2021 A | 14.000 | 0 | 0 | $0 |
| Richard S Shame | Chief Medical Officer | 28. Februar 2019 A | 32.021 | 0 | 0 | $0 |
| William A Hodder | Sr. VP - Corporate Development | 11. Oktober 2016 A | · | 0 | 0 | $0 |
| William D. Waddill | Direktor | 23. Juni 2026 M | 7.825 | 0 | 6 | $-5.580.420 |
| Bryan Giraudo | Direktor | 7. Mai 2026 M | 12.695 | 0 | 4 | $-5.918.880 |
| Harold E Selick | Direktor | 26. März 2026 M | 60.845 | 0 | 1 | $-2.520.000 |
| Lewis T Williams | Direktor | 17. Februar 2026 M | 7.825 | 0 | 1 | $-1.483.560 |
| Sarah A O'Dowd | Direktor | 2. Januar 2026 A | 7.825 | 0 | 0 | $0 |
| Daniel N Swisher JR | Direktor | 26. Oktober 2023 A | · | 0 | 0 | $0 |
| Sarah B. Noonberg | Direktor | 16. Januar 2023 A | 0 | 0 | 0 | $0 |
| Chaitan Khosla PHD | Direktor | 11. August 2020 M | 0 | 0 | 0 | $0 |
| Armen Shanafelt | Direktor | 29. Mai 2018 A | 2.099.482 | 0 | 0 | $0 |
| Julie Papanek | Direktor | 25. Mai 2017 A | 2.453.255 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 58 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PSCH · Invesco Exchange-Traded Fund Trust … | 4,93% | 61.551 SH | 2. Oktober 2026 | Täglich |
| XSMO · Invesco Exchange-Traded Fund Trust | 2,66% | 551.334 SH | 2. Oktober 2026 | Täglich |
| PBE · Invesco Exchange-Traded Fund Trust | 2,62% | 77.923 SH | 2. Oktober 2026 | Täglich |
| PTH · Invesco Exchange-Traded Fund Trust | 2,27% | 47.094 SH | 2. Oktober 2026 | Täglich |
| RZG · Invesco Exchange-Traded Fund Trust | 1,99% | 17.092 SH | 2. Oktober 2026 | Täglich |
| BBP · ETFis Series Trust I | 1,71% | 12.363 NS | 31. Juli 2026 | N-PORT |
| VAMO · Cambria ETF Trust | 1,00% | 7.935 NS | 31. Juli 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,89% | 25.844 SH | 2. Oktober 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,88% | 31.902 NS | 31. Juli 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,81% | 71.955 SH | 19. August 2026 | Täglich |
| IBB · iShares Trust | 0,66% | 466.476 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,60% | 4.579 SH | 2. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,59% | 579.401 SH | 11. September 2026 | Täglich |
| ESSC · Strategy Shares | 0,55% | 1.449 NS | 31. Juli 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,55% | 9.298 SH | 2. Oktober 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,44% | 65.879 SH | 19. August 2026 | Täglich |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,40% | 211.363 SH | 19. August 2026 | Täglich |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,39% | 16.778 NS | 31. Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,36% | 2.314 NS | 31. Juli 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,35% | 14.976 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,29% | 1.572.745 SH | 11. September 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,28% | 14.392 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,27% | 29.469 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,25% | 436 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,23% | 354.172 SH | 19. August 2026 | Täglich |
| ROSC · Lattice Strategies Trust | 0,23% | 1.028 NS | 31. Juli 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,22% | 851.812 SH | 19. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,17% | 27.056 SH | 19. August 2026 | Täglich |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,17% | 16.805 NS | 31. Juli 2026 | N-PORT |
| ESUM · Strategy Shares | 0,17% | 2.228 NS | 31. Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,13% | 24.877 SH | 11. September 2026 | Täglich |
| ISCG · iShares Trust | 0,11% | 7.049 SH | 11. September 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,11% | 4.495 NS | 31. Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,10% | 24.256 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,09% | 17.622 SH | 2. Oktober 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,09% | 1.475.028 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,09% | 153.362 SH | 19. August 2026 | Täglich |
| SMDX · Tidal Trust III | 0,08% | 772 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,08% | 693.286 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,07% | 3.201 SH | 11. September 2026 | Täglich |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,02% | 2.470 SH | 2. Oktober 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,01% | 3.216 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 78.521 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 16.255 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 1.782 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 2.045.389 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 49.344 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5.067 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,01% | 13.583 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 2.599 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 5.700 NS | 31. Juli 2026 | N-PORT |
| IJR · iShares Trust | · | 3.688.949 SH | 10. September 2026 | Täglich |
| IJT · iShares Trust | · | 571.914 SH | 9. September 2026 | Täglich |
| XJR · iShares Trust | · | 8.347 SH | 31. August 2026 | Täglich |
| ISCB · iShares Trust | · | 2.384 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 6.767 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 28.109 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 10.763 SH | 1. September 2026 | Täglich |
PTGX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 20 Analysten
KAUF
Median-Ziel
$171.00
+21,6%
7 35,0%
Starker Kauf
12 60,0%
Kauf
1 5,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
13 Analysten · 2026-10-04Mittelwert-Ziel $174.69 +24,2%
← Unter allen Zielen
Aktueller Preis $140.63
Tief$149.00
Mittelwert$174.69
Hoch$225.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | · |
| IBRX | $2.00B | -5.2 | 668.3% | -310.2% | 71.0% | · |
| PCVX | $6.05B | -8.2 | · | · | -26.6% | · |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | · |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | · |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | · |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | · |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | · |
| TGTX | $4.63B | 10.8 | 87.3% | 72.6% | 96.7% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 5,00
Einstieg
$98.42
R:R 5,00
BOUNCE_UP
Stop-Loss ausgelöst
Risiko 1
Belohnung 2,00
Einstieg
$88.31
R:R 2,00
Derzeit kein offenes Signal – keine Karte ist ausgefüllt, und das ist ehrlich.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026